Human VHL Antibody, R&D Systems™

Mouse Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB11435SP	R&D Systems MAB11435SP	25 μg
MAB11435100	R&D Systems MAB11435100	100 μg

Description

Von Hippel Lindau Monoclonal antibody specifically detects Von Hippel Lindau in Human samples. It is validated for Western Blot, Simple Western

Specifications

• Antigen: Von Hippel Lindau
• Dilution: Western Blot 2 μg/mL, Simple Western 20 μg/mL
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene Alias: elongin binding protein, HRCA1, Protein G7, pVHL, RCA1, VHL1, von Hippel-Lindau disease tumor suppressor, von Hippel-Lindau syndrome, von Hippel-Lindau tumor suppressor
• Immunogen: E. coli -derived recombinant human VHL, Asn150-Asp213, Accession # P40337
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.

• Clone: 1066402
• Applications: Western Blot, Simple Western
• Conjugate: Unconjugated
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: P40337
• Gene ID (Entrez): 7428
• Isotype: IgG1
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.